POLQ expression based on
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.58009999973174E-07 |
Normal-vs-Stage2 |
1.429680E-02 |
Normal-vs-Stage3 |
1.64120999999184E-05 |
Normal-vs-Stage4 |
3.129900E-02 |
Stage1-vs-Stage2 |
2.609200E-01 |
Stage1-vs-Stage3 |
2.401200E-04 |
Stage1-vs-Stage4 |
1.447190E-01 |
Stage2-vs-Stage3 |
1.497000E-01 |
Stage2-vs-Stage4 |
3.078800E-01 |
Stage3-vs-Stage4 |
9.814800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.70607972194148E-12 |
Normal-vs-AfricanAmerican |
1.66943999999614E-05 |
Normal-vs-Asian |
7.898200E-02 |
Caucasian-vs-AfricanAmerican |
1.944790E-01 |
Caucasian-vs-Asian |
1.216190E-01 |
AfricanAmerican-vs-Asian |
2.115400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.33066907387547E-16 |
Normal-vs-Female |
7.7119999997155E-07 |
Male-vs-Female |
4.139900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.55050000000467E-05 |
Normal-vs-Extreme_Weight |
6.28679996950154E-09 |
Normal-vs-Obese |
8.48919999851816E-08 |
Normal-vs-Extreme_Obese |
5.740700E-03 |
Normal_Weight-vs-Extreme_Weight |
5.280400E-02 |
Normal_Weight-vs-Obese |
5.726000E-01 |
Normal_Weight-vs-Extreme_Obese |
2.073800E-02 |
Extreme_Weight-vs-Obese |
6.412300E-02 |
Extreme_Weight-vs-Extreme_Obese |
3.902800E-01 |
Obese-vs-Extreme_Obese |
2.224400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.160280E-03 |
Normal-vs-Age(41-60Yrs) |
1.66489044772788E-12 |
Normal-vs-Age(61-80Yrs) |
2.98929999975606E-07 |
Normal-vs-Age(81-100Yrs) |
2.677800E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.358200E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.216100E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.322600E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.824400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.242360E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.873800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.68329794547617E-11 |
Normal-VS-Type2 PRCC |
1.55189999961891E-07 |
Normal-VS-KIRP CIMP |
3.040200E-04 |
Normal-VS-Unclassified PRCC |
7.08790000025772E-07 |
Type1 PRCC-VS-Type2 PRCC |
2.884400E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.123770E-03 |
Type1 PRCC-VS-Unclassified PRCC |
2.591200E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.757330E-03 |
Type2 PRCC-VS-Unclassified PRCC |
7.862000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.995450E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.26839999999395E-05 |
Normal-vs-N1 |
2.31410000000043E-05 |
Normal-vs-N2 |
2.355200E-01 |
N0-vs-N1 |
9.151900E-04 |
N0-vs-N2 |
3.872200E-01 |
N1-vs-N2 |
7.218200E-01 |
|
|